Iradimed Corp(IRMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:18 AM ET (Korea 9/11 17:18)
Full metrics table
| Index | RUT | P/E | 45.7 | EPS (ttm) | 1.79 | Insider Own | 34.87% | Shs Outstand | 12.8M | Perf Week | -4.99% |
| Market Cap | 1.05B | Forward P/E | 33.97 | EPS next Y | 15.31% | Insider Trans | -2.13% | Shs Float | 8.3M | Perf Month | -7.95% |
| Enterprise Value | 0.99B | PEG | 2.84 | EPS next Q | 0.55 | Inst Own | 61.96% | Short Float | 8.74% | Perf Quarter | -14.72% |
| Income | 0.02B | P/S | 12.12 | EPS this Y | 8.29% | Inst Trans | 3.02% | Short Ratio | 5.73 | Perf Half Y | -18.79% |
| Sales | 0.09B | P/B | 10.29 | EPS next 5Y | 11.98% | ROA | 20.82% | Short Interest | 0.73M | Perf YTD | -15.84% |
| Book/sh | 7.96 | P/C | 17.72 | EPS past 3/5Y | 19.88% 73.89% | ROE | 23.52% | 52W High | -24.12% ($107.90) | Perf Year | 15.07% |
| Cash/sh | 4.62 | P/FCF | 41.67 | Sales past 3/5Y | 16.28% 21.45% | ROIC | 22.66% | 52W Low | 21.3% ($67.49) | Perf 3Y | 76.18% |
| Dividend Est. | $0.77 (0.94%) | EV/EBITDA | 33.85 | EPS Y/Y TTM | 11.08% | Gross Margin | 75.86% | Volatility(W/M) | 3% 2.68% | Perf 5Y | 153.54% |
| Dividend TTM | 0.77 | EV/Sales | 11.44 | Sales Y/Y TTM | 11.21% | Oper. Margin | 31.92% | ATR (14) | 2.48 | Perf 10Y | 404.46% |
| Dividend Ex-Date | 2026/8/14 | Quick Ratio | 8.13 | EPS Q/Q | -9.87% | Profit Margin | 26.7% | RSI (14) | 28.25 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.46 | Sales Q/Q | 0.28% | SMA20 | -5.19% ($86.35) | Beta | 0.9 | Target Price | $118 |
| Payout | 38.88% | Debt/Eq | 0 | Earnings | 2026/7/31 | SMA50 | -10.42% ($91.39) | Rel Volume | 0.95 | Prev Close | $83.56 |
| Employees | 166 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 4.55% 0.57% | SMA200 | -13.26% ($94.39) | Avg Volume(3M) | 0.13M | Price | $81.87 |
| IPO | 2014/7/16 | Option/Short | Yes/Yes | Trades | 2768 | Volume | 120,198 | Change | -2.02% |
Company
IRMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
IRMD (Iradyamed) is a U.S. medical device company that specializes in the development, manufacturing, and sale of non-magnetic medical devices designed for safe use in magnetic resonance imaging (MRI) environments. The company supplies non-magnetic infusion pumps that enable intravenous delivery during MRI scans, as well as patient vital-sign monitoring systems. It has established a leading position in the niche market of MRI suites, where magnetic interference is a critical concern. Its primary customers are hospitals and acute-care medical facilities, and it sells its products in both the U.S. and international markets.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
IRMD makes money exceptionally well
31.92% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.3% this year.
Tap to view numbers
But it is not cheap
Trading at 45.7 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +76.2% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.94% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 62.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SAWS 0.03%
MGMT 0.01%
XHE 0.01%
AIMS 0.01%
SMAP 0.00%It ranks #4 in the industry
Based on market cap of $1B.
IRMD $1B PER 45.7
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is IRMD?
IRMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of IRMD?
The market cap of IRMD is approximately $1.0B, ranking 2,608 within its sector.
Does IRMD pay dividends?
IRMD has a dividend yield of approximately 0.94%, with an annual dividend of $0.77.
What is the P/E ratio of IRMD?
IRMD has a P/E ratio of approximately 45.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for IRMD?
IRMD has recorded a 52-week high of $107.90 and a low of $67.49.
